Experienced in Lactose Intolerance

Dr. Henry C. Lin

General Practice
746 W 79th St, 
Chicago, IL 
Experienced in Lactose Intolerance
746 W 79th St, 
Chicago, IL 
OverviewInsuranceLocationsClinical Research

Overview

Henry Lin is a primary care provider, practicing in General Practice in Chicago, Illinois. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Lactose Intolerance. His top areas of expertise are Alagille Syndrome, Cholestasis, Biliary Atresia, Vitrectomy, and Liver Transplant.

His clinical research consists of co-authoring 167 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Lactose Intolerance.

Specialties
General Practice
Licenses
General Practice in IL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

746 W 79th St, Chicago, IL 60620

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 3, Multicenter, Randomized Study With 2 Different Doses of Prucalopride Administered to Male and Female Pediatric Subjects Aged 6 Months to 17 Years With Functional Constipation, Consisting of a 12-week Double-blind, Placebo-controlled Part (Part A) to Evaluate Efficacy and Safety Followed by a 36-week Double-blind Extension Part (Part B) to Document Long-term Safety up to Week 48
Phase 3, Multicenter, Randomized Study With 2 Different Doses of Prucalopride Administered to Male and Female Pediatric Subjects Aged 6 Months to 17 Years With Functional Constipation, Consisting of a 12-week Double-blind, Placebo-controlled Part (Part A) to Evaluate Efficacy and Safety Followed by a 36-week Double-blind Extension Part (Part B) to Document Long-term Safety up to Week 48
Enrollment Status: Terminated
Publish Date: June 06, 2024
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT)
A Phase 3 Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT)
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: Odevixibat
Study Phase: Phase 3
View 1 Less Clinical Trial

1 Total Publications

Glow gel hand washing in the waiting room: a novel approach to improving hand hygiene education.
Glow gel hand washing in the waiting room: a novel approach to improving hand hygiene education.
Journal: Infection control and hospital epidemiology
Published: June 14, 2011

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lin's expertise for a condition
ConditionClose
View All 45 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile